# Progress Note 04 — Preventive Visit

> **SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD**

- Patient: Sonny Liston (real historical name used in a fictional teaching record)
- Synthetic MRN: HR-BX007-SYN-TD
- Date: 1969-08-11
- Fictional facility: St. Posthumous Health Center
- Fictional author: Malcolm Achebe-Whitford, MD
- Calendar frame: true historical dates (modern content is anachronistic)

> True-date frame: synthetic events are moved into the patient's historical lifetime. Codes, instruments, and treatments remain modern and are anachronistic.

- Visit type: Preventive Visit
- Services: CPT 99395 (periodic preventive medicine, established patient, age 18 to 39)

## Chief complaint

Periodic adult preventive visit. **S**

## History of present illness

Sonny Liston is a 37-year-old professional heavyweight boxer with stage 2 hypertension and moderate alcohol use disorder who comes for his yearly preventive visit, three weeks after his four-week review. He takes amlodipine 10 mg and valsartan 160 mg each morning and naltrexone 50 mg each morning, and shows the picture card he keeps in his gym bag. His home readings, which the talking monitor reads out and he leaves on the clinic voice line, average 128/80 mmHg. Since starting naltrexone he has three or four drinks on two evenings a week and none on other days. Mild ankle swelling after long runs in the heat goes by morning. He has had no chest pain, breathlessness or palpitations. He wants to be cleared to fight again this fall. **S**

| Element | Detail |
|---|---|
| Visit | Periodic adult preventive visit, age 37 |
| Blood pressure | Clinic 128/80 mmHg; home average 128/80 mmHg |
| Alcohol | Three or four drinks on two evenings a week on naltrexone |
| Mood | PHQ-2 0 |
| Medicines | Amlodipine 10 mg and valsartan 160 mg; naltrexone 50 mg |

## Health risk assessment

Asked aloud by the nurse in a private room, one question at a time, with answers recorded for him; reviewed by Dr. Achebe-Whitford. **S**

| Domain | Finding |
|---|---|
| Self-rated health | Good; feels stronger since drinking less |
| Psychosocial | Married; close to his trainer and gym; money is steady from fighting and exhibitions |
| Tobacco | Does not smoke |
| Alcohol and drugs | Drinking reduced on naltrexone; no drug use (DAST-10 0 at intake) |
| Physical activity | Trains six days a week: roadwork, bag work and sparring |
| Nutrition | Large meals; eats out often; cutting down on salted meats and fast food |
| Sleep | Seven to eight hours |
| Driving and injury | Drives himself; wears a seat belt; agreed never to drive after drinking |
| Home safety | No firearms in the home; smoke detector working |
| Health literacy | Prefers spoken explanations and pictures; uses the picture card and leaves his readings on the clinic voice line |
| Dental | No dentist for many years; one back tooth sore when chewing |

## Review of systems

| System | Result | Finding |
|---|---|---|
| Constitutional | Negative | No fever, night sweats or weight loss |
| Eyes | Negative | No change in vision |
| Ears, nose, mouth, and throat | Positive | A sore lower back tooth when chewing; no hearing loss |
| Cardiovascular | Positive | Mild ankle swelling after long runs in the heat, gone by morning; no chest pain, palpitations or fainting |
| Respiratory | Negative | No cough or breathlessness |
| Gastrointestinal | Negative | No nausea on naltrexone; no abdominal pain, yellowing or bleeding |
| Genitourinary | Negative | No urinary symptoms |
| Musculoskeletal | Negative | No shoulder or jaw pain with training |
| Integumentary | Negative | No rashes or sores |
| Neurological | Negative | No headaches, dizziness, numbness or memory problems |
| Psychiatric | Negative | Mood good; PHQ-2 0; no thoughts of suicide |

11 systems reviewed. **S**

## Current medications

- Amlodipine 10 mg and valsartan 160 mg combined oral tablet, one tablet each morning **S**
- Naltrexone 50 mg oral tablet, one tablet each morning **S**

## Allergies

- No known allergy **S**

## Objective

BP 128/80 mmHg; pulse 56 bpm; respirations 14/min; temperature 36.6 °C; oxygen saturation 99% on room air; weight 97.6 kg; BMI 28.5 kg/m². All vital signs are synthetic.

PHQ-2: 0. All results are synthetic.

## Immunizations given today

- Tdap vaccine; no record of an earlier tetanus booster **S**
- Hepatitis B vaccine (HepB-CpG), dose 1 of 2, recommended for all adults 19 to 59 **S**

## Physical examination

| System | Finding |
|---|---|
| Constitutional | Powerfully built and well; weight 97.6 kg, BMI 28.5; blood pressure 128/80 mmHg; pulse 56 |
| Eyes | Visual acuity 20/20 each eye by picture chart; fundi with no hypertensive changes |
| Mouth | Large cavity in a lower left molar, tender to tapping; gums otherwise healthy; old healed jaw fracture without deformity |
| Cardiovascular | Regular slow rhythm; no murmur or gallop; trace ankle edema; foot pulses normal |
| Respiratory | Clear to auscultation |
| Abdomen | Soft, non-tender; liver not enlarged |
| Skin | Old scars over both brows; no lesions of concern |

All examination findings are synthetic. **S**

## Assessment and plan

1. **Periodic adult preventive visit completed**. Health risk assessment reviewed and the prevention plan explained out loud with a picture handout; he repeated the main points back. LDL 122 mg/dL at intake; at 37 a 10-year risk estimate is low and a statin is not indicated, so lifestyle and blood pressure control are the focus. HIV, hepatitis C and hepatitis B screening drawn today; consent read aloud. **S**
   - Tdap and the first hepatitis B vaccine dose today; second hepatitis B dose in one month.
   - Dental clinic for the decayed molar.
   - Results of the screening tests by phone, in a voice message he can replay.
   - Next preventive visit in one year.
2. **Hypertension, stage 2** (I10). Near goal on the higher dose; trace ankle edema from amlodipine, not bothering him. **S**
   - Continue amlodipine 10 mg and valsartan 160 mg.
   - Leg elevation after long runs.

## Personalized prevention plan

A written copy was given to the patient. **S**

| Service | Status | Detail |
|---|---|---|
| Blood pressure | Completed today | 128/80 mmHg on treatment |
| Lipid screening and statin | Up to date | Total cholesterol 204, HDL 58, LDL 122, triglycerides 120 mg/dL at intake; statin not indicated at 37 with low 10-year risk |
| Prediabetes and type 2 diabetes screening | Up to date | Hemoglobin A1c 5.4% and fasting glucose 92 mg/dL at intake |
| Colorectal cancer screening | Not indicated | Begins at 45 |
| HIV screening | Completed today | Routine one-time screening for ages 15 to 65; consent read aloud |
| Hepatitis C screening | Completed today | One-time screening for all adults |
| Hepatitis B screening | Completed today | Triple panel, recommended once for all adults |
| Depression screening | Completed today | PHQ-2 0, read aloud |
| Unhealthy alcohol use | Completed today | In treatment for moderate alcohol use disorder; drinking reduced |
| Unhealthy drug use | Up to date | DAST-10 0 at intake |
| Tobacco cessation | Not indicated | Does not smoke |
| Tetanus, diphtheria, and pertussis | Completed today | Tdap today; no record of an earlier booster |
| Hepatitis B vaccine | Completed today | Dose 1 of 2 (HepB-CpG) today; dose 2 in one month |
| Influenza vaccine | Due | When this season's vaccine arrives in the fall |
| COVID-19 vaccine | Due | Offered with the influenza vaccine in the fall |
| Dental care | Referred | Community dental clinic for a decayed lower molar |

## Advance care planning

Brief discussion, read aloud and explained in plain words. He was asked who should speak for him if he were badly hurt in the ring or could not speak for himself; he named a health care agent, recorded in the chart and not named here. He said he would want everything done to recover from an injury. He chose to sign a health care power of attorney after it was read to him in full, with the nurse as witness, and was given an audio copy of what it says. **S**

## Guideline basis

- 2025 AHA/ACC/AANP/AAPA/ABC/ACCP/ACPM/AGS/AMA/ASPC/NMA/PCNA/SGIM Guideline for the Prevention, Detection, Evaluation and Management of High Blood Pressure in Adults (2025), American Heart Association and American College of Cardiology (Circulation 2025;152(11):e114-e218)
- AHRQ Health Literacy Universal Precautions Toolkit, 3rd Edition (2024), Agency for Healthcare Research and Quality
- Medicare Preventive Services reference: visit templates, screening cascades, and documentation elements (2026), Aether Forge
- USPSTF A and B Recommendations (2026), U.S. Preventive Services Task Force
- Adult Immunization Schedule by Age (2026), Centers for Disease Control and Prevention

## Follow-up

- Three-month review in six weeks. Second hepatitis B dose in one month. Dental clinic as booked. Influenza and COVID-19 vaccines in the fall. Next preventive visit in one year. **S**
- Next scheduled visit 1969-09-22: three-month review: blood pressure, liver tests and drinking on naltrexone. **S**
